Standard Standard

The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. / F, Pellicano; MT, Scott; GV, Helgason et al.
In: Stem Cells, Vol. 32, No. 9, 18.08.2014, p. 2324-2337.

Research output: Contribution to journalArticlepeer-review

HarvardHarvard

F, P, MT, S, GV, H, LE, H, EK, A, M, A-OD, M, C, A, P, BJ, H, AD, W & TL, H 2014, 'The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.', Stem Cells, vol. 32, no. 9, pp. 2324-2337. https://doi.org/10.1002/stem.1748

APA

F, P., MT, S., GV, H., LE, H., EK, A., M, A.-OD., M, C., A, P., BJ, H., AD, W., & TL, H. (2014). The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells, 32(9), 2324-2337. https://doi.org/10.1002/stem.1748

CBE

MLA

VancouverVancouver

F P, MT S, GV H, LE H, EK A, M AOD et al. The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells. 2014 Aug 18;32(9):2324-2337. doi: 10.1002/stem.1748

Author

F, Pellicano ; MT, Scott ; GV, Helgason et al. / The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. In: Stem Cells. 2014 ; Vol. 32, No. 9. pp. 2324-2337.

RIS

TY - JOUR

T1 - The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors.

AU - F, Pellicano

AU - MT, Scott

AU - GV, Helgason

AU - LE, Hopcroft

AU - EK, Allan

AU - M, Aspinall-O'Dea

AU - M, Copland

AU - A, Pierce

AU - BJ, Huntly

AU - AD, Whetton

AU - TL, Holyoake

PY - 2014/8/18

Y1 - 2014/8/18

U2 - 10.1002/stem.1748

DO - 10.1002/stem.1748

M3 - Article

VL - 32

SP - 2324

EP - 2337

JO - Stem Cells

JF - Stem Cells

SN - 1549-4918

IS - 9

ER -